OZEMPIC
- Product NDC
- 0169-1709
- 11-digit product format
- 001691709
- Labeler code
- 0169
- Product ID
- 0169-1709_5176eed4-f8f8-4f88-a079-11f16864f40a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oral semaglutide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Application
- NDA213051
- Marketing category
- NDA
- Marketing start
- 2026-04-27
- Substance
- SEMAGLUTIDE
- Active strength
- 9 mg/1
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 53AXN4NNHX | SEMAGLUTIDE | 910463-68-2 | SEMAGLUTIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0169-1709-30 | 00169170930 | 30 TABLET in 1 BOTTLE, PLASTIC (0169-1709-30) | 30 tablet | 2026-04-27 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| OZEMPIC | Novo Nordisk Pharmaceutical Industries, LP | 2026-01-30 | HUMAN PRESCRIPTION DRUG LABEL | 13 |
| RYBELSUS | Novo Nordisk | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL | 10 |